# Study of the Effect of SR57667B in Patients With Alzheimer's Disease

> **NCT00285025** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 500 (—)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** SR57667B

## Key facts

- **NCT ID:** NCT00285025
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 500 (—)
- **Last updated:** 2006-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00285025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00285025, "Study of the Effect of SR57667B in Patients With Alzheimer's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00285025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*